Ligand validation:6Q94

NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE

NAP is a Ligand Of Interest in 6Q94 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6Q94_NAP_F_402	59%	61%	0.162	0.975	0.64	0.86	-	1	1	0	83%	0.8333
6Q94_NAP_B_401	58%	25%	0.167	0.977	0.81	2.2	1	7	0	0	83%	0.8333
6Q94_NAP_D_401	58%	60%	0.165	0.974	0.68	0.86	-	1	1	0	83%	0.8333
6Q94_NAP_G_401	58%	62%	0.169	0.978	0.72	0.75	-	1	0	0	83%	0.8333
6Q94_NAP_C_401	55%	57%	0.171	0.971	0.69	0.97	-	2	0	0	83%	0.8333
6Q94_NAP_E_401	53%	52%	0.18	0.972	0.85	1	1	2	0	0	83%	0.8333
6Q94_NAP_H_401	51%	57%	0.169	0.955	0.68	0.96	-	2	3	0	83%	0.8333
6Q94_NAP_A_401	47%	55%	0.193	0.964	0.74	0.99	-	3	1	0	83%	0.8333
5IN5_NAP_C_1001	99%	9%	0.054	0.986	2.61	1.81	15	11	0	0	100%	1
5IN4_NAP_D_402	98%	14%	0.064	0.988	2.17	1.67	9	10	0	0	100%	1
6GPK_NAP_D_404	95%	32%	0.068	0.974	1.33	1.37	6	6	0	0	100%	1
6GPJ_NAP_A_403	95%	45%	0.075	0.978	0.86	1.24	2	8	0	0	100%	1
6GPL_NAP_E_4002	87%	37%	0.103	0.975	1.08	1.37	2	6	1	0	100%	1
2DBQ_NAP_A_401	100%	24%	0.017	0.998	1.42	1.71	7	16	0	0	100%	1
2EXX_NAP_A_3698	100%	10%	0.025	0.996	1.63	2.7	7	18	9	0	100%	1
2X9G_NAP_B_1269	100%	46%	0.031	0.997	0.96	1.14	1	5	0	0	100%	1
2J8T_NAP_A_1316	100%	49%	0.033	0.996	0.97	1.01	3	2	1	0	100%	1
3LQL_NAP_A_500	100%	43%	0.035	0.996	1.13	1.07	3	4	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.